Core Insights - Defence Therapeutics is focused on advancing a proprietary intracellular delivery platform aimed at enhancing the efficacy and safety of antibody-based and radiotherapeutic treatments [1][4] - The company will present at the Life Sciences Virtual Investor Forum on December 11, 2025, providing an opportunity for real-time investor engagement [1][2] Company Overview - Defence Therapeutics is a biotechnology company based in Montreal, utilizing its ACCUM® technology for precision delivery of biologics to target cells, thereby improving their potency and efficacy [4] - The company aims to expand patient access and market opportunities through its innovative delivery platform [4] Event Details - The presentation will take place on December 11, 2025, at 11:00 am ET, with opportunities for one-on-one meetings available on the same day and on December 15 and 16 [2] - An archived webcast will be available for those unable to attend the live event [2][3] Investor Engagement - Virtual Investor Conferences (VIC) provides a platform for publicly traded companies to present directly to investors, facilitating enhanced communication and engagement [5][6] - VIC replicates the components of an on-site investor conference, allowing companies to connect with investors and schedule targeted meetings [6]